Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrahepatic HCV RNA and Telaprevir Kinetics
NCT00892697Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- May 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of telaprevir in hepatitis C (HCV), sponsored by Weill Cornell Medicine. Started May 2009; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00892697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00892697.